BARINTHUS BIOTHERAPEUTICS PLC Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet · last filed 2022-03-25
- BARINTHUS BIOTHERAPEUTICS PLC fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers, net for fiscal 2021 was $0.00.
- BARINTHUS BIOTHERAPEUTICS PLC fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers, net for fiscal 2020 was $0.00.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-25 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 |